Luis Vascello, MD
Pain Medicine · Lexington, KYNPI 1679668065
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 43.2% of the total.
Across 217 payments — averaging $77.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$3K
- Nevro Corp.$1K
- Spinal Simplicity, LLC$1K
- Spinefrontier, Inc.$1K
- Painteq LLC$864
- plus $2K from 15 others
What the payments were for
- Travel & lodging$8,89353%
- Food & beverage$7,16142%
- Education$8475%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 115 | $7,299 |
| Boston Scientific | 16 | $3,106 |
| Nevro Corp. | 15 | $1,378 |
| Spinal Simplicity, LLC | 13 | $1,321 |
| Spinefrontier, Inc. | 5 | $1,059 |
| Painteq LLC | 3 | $864 |
| Globus Medical | 11 | $741 |
| Abbott | 12 | $473 |
| Saluda Medical Americas, Inc. | 6 | $124 |
| SPR Therapeutics, Inc | 6 | $117 |
| Biotronik NRO, Inc. | 3 | $104 |
| Vertos Medical, Inc. | 2 | $96 |
| Relievant Medsystems, Inc. | 1 | $57 |
| Averitas Pharma Inc. | 2 | $37 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Flowonix Medical Incorporated | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $19 |
| Neuronetics, Inc. | 1 | $17 |
| Avanos Medical | 1 | $16 |
| MML US, Inc. | 1 | $15 |
| Curonix LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$2,728
- VANTA ADAPTIVESTIM$2,492
- Senza$1,225
- HA MINUTEMAN G3-R$1,083
- Superion Indirect Decompression System$962
- PAINTEQ$807
- InSpan$807
- SIJFuse$807
- FacetFuse$807
- NanoFuse$807
- INTELLIS ADAPTIVESTIM$463
- Vyrsa V1$280
- CLINICAL TRIAL PRODUCT$152
- ETERNA$148
- WaveWriter Alpha Prime 16$142
- Omnia$131
- SYNCHROMEDII$117
- KYPHON Balloon Kyphoplasty$106
How this compares
$16,901 in reported general payments places this provider in the 85th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 59 | $3,015 |
| Duloxetine Hcl | 80 | $1,085 |
| Venlafaxine Hcl | 15 | $409 |
| Nortriptyline Hcl | 50 | $398 |
| Gabapentin | 56 | $371 |
| Tizanidine Hcl | 104 | $291 |
| Mupirocin | 49 | $261 |
| Baclofen | 22 | $179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 73 | $168 |
| Tramadol Hcl | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lexington
- Christopher MallardLexington$47K
- Mazhar RasulLexington$30K
- Stuart CowleyLexington$19K
- Michael HarnedLexington$17K
- Shawn MilburnLexington$17K
- Brandon GishLexington$13K
- Timothy MimsLexington$11K
- Manoochehr MazloomdoostLexington$8K
- Maged FamLexington$7K
- Oliver JamesLexington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.